{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:52:17Z","timestamp":1792068737572,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02483-9","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:13:31Z","timestamp":1789146811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of SGLT-2 inhibitors on thyroid-stimulating hormone and systemic immune-inflammation index in type 2 diabetes: a retrospective study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-5765","authenticated-orcid":false,"given":"Seyit Murat","family":"Bayram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enes","family":"\u00dc\u00e7g\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eule","family":"Canlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Cinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Menek\u015fe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lknur Alkan","family":"Ku\u015fabbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erman","family":"\u00c7akal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"2483_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"2483_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"GJ Canaris","year":"2000","unstructured":"Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526\u201334.","journal-title":"Arch Intern Med"},{"issue":"6","key":"2483_CR3","first-page":"355","volume":"76","author":"M Centeno Maxzud","year":"2016","unstructured":"Centeno Maxzud M, G\u00f3mez Rasjido L, Fregenal M, Arias Calafiore F, C\u00f3rdoba Lanus M, D\u2019Urso M, Luciardi H. [Prevalence of thyroid dysfunction in patients with type 2 diabetes mellitus]. Med (B Aires). 2016;76(6):355\u20138.","journal-title":"Med (B Aires)"},{"issue":"2","key":"2483_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s13340-018-0352-4","volume":"9","author":"M Nishi","year":"2018","unstructured":"Nishi M. Diabetes mellitus and thyroid diseases. Diabetol Int. 2018;9(2):108\u201312.","journal-title":"Diabetol Int"},{"issue":"1","key":"2483_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2265.2011.04029.x","volume":"75","author":"LH Duntas","year":"2011","unstructured":"Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf). 2011;75(1):1\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2483_CR6","doi-asserted-by":"publisher","first-page":"1245199","DOI":"10.3389\/fendo.2023.1245199","volume":"14","author":"Y Nie","year":"2023","unstructured":"Nie Y, Zhou H, Wang J, Kan H. Association between systemic immune-inflammation index and diabetes: a population-based study from the NHANES. Front Endocrinol (Lausanne). 2023;14:1245199.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2483_CR7","doi-asserted-by":"crossref","unstructured":"Aljuraiban GS, Alharbi FJ, Aljohi AO, Almeshari AZ, Alotaibi MN, AlShammari SS, Al-Musharaf S, Aldhwayan MM, Abudawood M. Systemic Immune-Inflammation Index in Relation to Diabetes Markers in Saudi Adults: A Retrospective Study. Med (Kaunas) 2024;60(3).","DOI":"10.3390\/medicina60030442"},{"issue":"1","key":"2483_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12902-023-01509-w","volume":"23","author":"C Cao","year":"2023","unstructured":"Cao C, Li C, Li X, Sun W, Wang Y. Association of systemic immune-inflammation index (SII) and aggregate index of systemic inflammation (AISI) with thyroid nodules in patients with type 2 diabetes mellitus: a retrospective study. BMC Endocr Disord. 2023;23(1):251.","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"2483_CR9","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-15-0133","volume":"225","author":"EM de Vries","year":"2015","unstructured":"de Vries EM, Fliers E, Boelen A. The molecular basis of the non-thyroidal illness syndrome. J Endocrinol. 2015;225(3):R67\u201381.","journal-title":"J Endocrinol"},{"issue":"9","key":"2483_CR10","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2337\/dc09-0273","volume":"32","author":"C Cappelli","year":"2009","unstructured":"Cappelli C, Rotondi M, Pirola I, Agosti B, Gandossi E, Valentini U, De Martino E, Cimino A, Chiovato L, Agabiti-Rosei E, et al. TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care. 2009;32(9):1589\u201390.","journal-title":"Diabetes Care"},{"issue":"1","key":"2483_CR11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1210\/jc.2005-1210","volume":"91","author":"RA Vigersky","year":"2006","unstructured":"Vigersky RA, Filmore-Nassar A, Glass AR. Thyrotropin suppression by metformin. J Clin Endocrinol Metab. 2006;91(1):225\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2483_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.4103\/ijem.IJEM_85_17","volume":"21","author":"V Gupta","year":"2017","unstructured":"Gupta V, Canovatchel W, Lokesh BN, Santani R, Garodia N. Sodium-glucose Cotransporter-2 Inhibitors: Moving Beyond the Glycemic Treatment Goal. Indian J Endocrinol Metab. 2017;21(6):909\u201318.","journal-title":"Indian J Endocrinol Metab"},{"key":"2483_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","volume":"20","author":"L Xu","year":"2017","unstructured":"Xu L, Nagata N, Nagashimada M, Zhuge F, Ni Y, Chen G, Mayoux E, Kaneko S, Ota T. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice. EBioMedicine. 2017;20:137\u201349.","journal-title":"EBioMedicine"},{"issue":"7","key":"2483_CR14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00424-024-02967-4","volume":"476","author":"N Bastawy","year":"2024","unstructured":"Bastawy N, El-Mosallamy A, Aljuaydi SH, AbuBakr HO, Rasheed RA, Sadek AS, Khattab RT, Abualyamin WB, Abdelaal SE, Boushra AF. SGLT2 inhibitor as a potential therapeutic approach in hyperthyroidism-induced cardiopulmonary injury in rats. Pflugers Arch. 2024;476(7):1125\u201343.","journal-title":"Pflugers Arch"},{"issue":"1","key":"2483_CR15","doi-asserted-by":"publisher","first-page":"102704","DOI":"10.1016\/j.dsx.2022.102704","volume":"17","author":"S Okada","year":"2023","unstructured":"Okada S, Isoda A, Hoshi H, Okada J, Okada K, Yamada E, Saito T, Watanabe T, Kikkawa K, Ohshima K. The ratio of free triiodothyronine to free thyroxine is regulated differently in patients with type 2 diabetes mellitus treated and not treated with sodium glucose cotransporter 2 inhibitors. Diabetes Metab Syndr. 2023;17(1):102704.","journal-title":"Diabetes Metab Syndr"},{"key":"2483_CR16","doi-asserted-by":"publisher","first-page":"9920286","DOI":"10.1155\/ije\/9920286","volume":"2025","author":"M Sanjari","year":"2025","unstructured":"Sanjari M, Sadeghi N, Amirkhosravi L, Hadavizadeh M, Naghibzadeh-Tahami A, Safi Z. Effect of Empagliflozin on Serum Levels of Thyroid Hormones Among Prediabetic and Diabetic Patients. Int J Endocrinol. 2025;2025:9920286.","journal-title":"Int J Endocrinol"},{"key":"2483_CR17","doi-asserted-by":"publisher","first-page":"1871530","DOI":"10.1155\/2018\/1871530","volume":"2018","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang Y, Tao XJ, Li Q, Li FF, Lee KO, Li DM, Ma JH. Relationship between Thyroid Function and Kidney Function in Patients with Type 2 Diabetes. Int J Endocrinol. 2018;2018:1871530.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"2483_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ndt\/gfu303","volume":"30","author":"CM Rhee","year":"2015","unstructured":"Rhee CM, Kalantar-Zadeh K, Streja E, Carrero JJ, Ma JZ, Lu JL, Kovesdy CP. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol Dial Transpl. 2015;30(2):282\u20137.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"2483_CR19","doi-asserted-by":"publisher","first-page":"bvag001","DOI":"10.1210\/jendso\/bvag001","volume":"10","author":"F Di Giacomo Barbagallo","year":"2026","unstructured":"Di Giacomo Barbagallo F, Bosco G, Di Marco M, Scilletta S, Miano N, Marted\u00ec M, Privitera I, Papa MC, Piazza C, Valenza F, et al. Assessment of N\/L ratio and subclinical atherosclerosis in FH subjects with or without LDLR mutation. J Endocr Soc. 2026;10(3):bvag001.","journal-title":"J Endocr Soc"},{"issue":"1 Suppl 1","key":"2483_CR20","first-page":"S27","volume":"48","author":"2","year":"2025","unstructured":"2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S27\u201349.","journal-title":"Diabetes Care"},{"issue":"23","key":"2483_CR21","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212\u201322.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2483_CR22","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1111\/dom.15586","volume":"26","author":"L Buttice","year":"2024","unstructured":"Buttice L, Ghani M, Suthakar J, Gnanalingham S, Carande E, Kennedy BWC, Pitcher A, Gamble JHP, Ahmad M, Lewis A, et al. The effect of sodium-glucose cotransporter-2 inhibitors on inflammatory biomarkers: A meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2024;26(7):2706\u201321.","journal-title":"Diabetes Obes Metab"},{"key":"2483_CR23","doi-asserted-by":"publisher","first-page":"1045235","DOI":"10.3389\/fphar.2022.1045235","volume":"13","author":"D Wang","year":"2022","unstructured":"Wang D, Liu J, Zhong L, Li S, Zhou L, Zhang Q, Li M, Xiao X. The effect of sodium-glucose cotransporter 2 inhibitors on biomarkers of inflammation: A systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2022;13:1045235.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2483_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12902-023-01512-1","volume":"23","author":"S Gohari","year":"2023","unstructured":"Gohari S, Ismail-Beigi F, Mahjani M, Ghobadi S, Jafari A, Ahangar H, Gohari S. The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials. BMC Endocr Disord. 2023;23(1):257.","journal-title":"BMC Endocr Disord"},{"issue":"8","key":"2483_CR25","doi-asserted-by":"publisher","first-page":"bvaf075","DOI":"10.1210\/jendso\/bvaf075","volume":"9","author":"H Wei","year":"2025","unstructured":"Wei H, Ye L, Li M, Huang S, Mo Z. Effect of GLP-1 RA and SGLT2I on Biomarkers of Oxidative Stress in T2DM: A Systematic Review and Meta-analysis. J Endocr Soc. 2025;9(8):bvaf075.","journal-title":"J Endocr Soc"},{"key":"2483_CR26","doi-asserted-by":"publisher","first-page":"248563","DOI":"10.1155\/2013\/248563","volume":"2013","author":"A Mima","year":"2013","unstructured":"Mima A. Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets. J Diabetes Res. 2013;2013:248563.","journal-title":"J Diabetes Res"},{"issue":"4","key":"2483_CR27","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/2211-5463.12400","volume":"8","author":"A Mima","year":"2018","unstructured":"Mima A, Yasuzawa T, King GL, Ueshima S. Obesity-associated glomerular inflammation increases albuminuria without renal histological changes. FEBS Open Bio. 2018;8(4):664\u201370.","journal-title":"FEBS Open Bio"},{"issue":"13","key":"2483_CR28","doi-asserted-by":"publisher","first-page":"8424","DOI":"10.1167\/iovs.12-10207","volume":"53","author":"A Mima","year":"2012","unstructured":"Mima A, Qi W, Hiraoka-Yamomoto J, Park K, Matsumoto M, Kitada M, Li Q, Mizutani K, Yu E, Shimada T, et al. Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes. Invest Ophthalmol Vis Sci. 2012;53(13):8424\u201332.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"2483_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jdiacomp.2018.04.011","volume":"32","author":"A Mima","year":"2018","unstructured":"Mima A. Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease. J Diabetes Complications. 2018;32(7):720\u20135.","journal-title":"J Diabetes Complications"},{"issue":"5","key":"2483_CR30","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s12325-021-01735-5","volume":"38","author":"A Mima","year":"2021","unstructured":"Mima A. Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease. Adv Ther. 2021;38(5):2201\u201312.","journal-title":"Adv Ther"},{"key":"2483_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijcard.2022.07.048","volume":"367","author":"J Fu","year":"2022","unstructured":"Fu J, Xu H, Wu F, Tu Q, Dong X, Xie H, Cao Z. Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role. Int J Cardiol. 2022;367:56\u201362.","journal-title":"Int J Cardiol"},{"key":"2483_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bcp.2018.03.013","volume":"152","author":"C Xu","year":"2018","unstructured":"Xu C, Wang W, Zhong J, Lei F, Xu N, Zhang Y, Xie W. Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells. Biochem Pharmacol. 2018;152:45\u201359.","journal-title":"Biochem Pharmacol"},{"key":"2483_CR33","doi-asserted-by":"publisher","first-page":"110206","DOI":"10.1016\/j.cellsig.2021.110206","volume":"90","author":"L Yang","year":"2022","unstructured":"Yang L, Liang B, Li J, Zhang X, Chen H, Sun J, Zhang Z. Dapagliflozin alleviates advanced glycation end product induced podocyte injury through AMPK\/mTOR mediated autophagy pathway. Cell Signal. 2022;90:110206.","journal-title":"Cell Signal"},{"key":"2483_CR34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","volume":"104","author":"TM Lee","year":"2017","unstructured":"Lee TM, Chang NC, Lin SZ. Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts. Free Radic Biol Med. 2017;104:298\u2013310.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"2483_CR35","first-page":"121","volume":"7","author":"L Xu","year":"2018","unstructured":"Xu L, Ota T. Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization. Adipocyte. 2018;7(2):121\u20138.","journal-title":"Adipocyte"},{"issue":"1","key":"2483_CR36","doi-asserted-by":"publisher","first-page":"e000783","DOI":"10.1136\/bmjdrc-2019-000783","volume":"7","author":"L Xu","year":"2019","unstructured":"Xu L, Nagata N, Chen G, Nagashimada M, Zhuge F, Ni Y, Sakai Y, Kaneko S, Ota T. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet. BMJ Open Diabetes Res Care. 2019;7(1):e000783.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"2483_CR37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12933-025-02769-7","volume":"24","author":"S Scilletta","year":"2025","unstructured":"Scilletta S, Di Marco M, Miano N, Capuccio S, Musmeci M, Bosco G, Di Giacomo Barbagallo F, Marted\u00ec M, La Rocca F, Vitale A, et al. Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable? Cardiovasc Diabetol. 2025;24(1):222.","journal-title":"Cardiovasc Diabetol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02483-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02483-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02483-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:19:25Z","timestamp":1792066765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02483-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2483"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02483-9","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Ankara Etlik City Hospital (Approval No: AE\u015eH-BADEK2-2025-220).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the retrospective nature of the study, data were obtained from the hospital information system and anonymized before analysis. Therefore, the requirement for individual informed consent was waived by the Ethics Committee.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"320"}}